Sbir topic 257, "instruments and devices that preserve molecular profiles in tumors"

Ended Definitive Contract Awarded Last action

Contract number
HHSN261200900073C
Awardee
Awarding agency
Obligated
$249,792

Award facts

Contract value 100% obligated
$249,792.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 5 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Houston, TX 77054, USA
Research
SBIR Program Phase I Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 1 $0
Original award $249,792

About this award

The National Cancer Institute (NCI) awarded a $249,792 Small Business Innovation Research (SBIR) Phase I contract to Biotex, Inc. to develop "Instruments and Devices that Preserve Molecular Profiles in Tumors" under SBIR Topic 257. The contract is a firm-fixed-price definitive contract with a period of performance ending on June 30, 2010. This SBIR contract supports the NCI's research objectives related to advancing cancer diagnostics and therapeutics.

Quick answers

Who was awarded contract HHSN261200900073C?

HHSN261200900073C was awarded to Biotex, Inc. by National Cancer Institute (National Institutes of Health) on September 30, 2009.

How much is contract HHSN261200900073C worth?

The government has obligated $249,792 on HHSN261200900073C.

Was contract HHSN261200900073C competed?

The extent of competition for HHSN261200900073C was full and open competition after exclusion of sources. The government received 5 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award